BackOSE Immunotherapeutics S.A. Overview

OSE Immunotherapeutics S.A. Total Liabilities

Track OSE Immunotherapeutics S.A.'s total liabilities ($51M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Total Liabilities
$51.10M
↓ 15.04% YoYΔ $-9.05M vs prior year quarter

Peer trimmed avg / median

Loading

OSE Immunotherapeutics S.A. Total Liabilities History

Loading

OSE Immunotherapeutics S.A. vs. peers: Total Liabilities Comparison

Loading

OSE Immunotherapeutics S.A. Total Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

OSE Immunotherapeutics S.A. (ORPOF) FAQ

OSE Immunotherapeutics S.A. (ORPOF) currently reports a total liabilities of $51M as of December 2025. That compares with $60M in the prior-year period — down 15.0% year over year. Use the charts on this page to explore OSE Immunotherapeutics S.A.'s total liabilities history and peer comparisons.

OSE Immunotherapeutics S.A.'s total liabilities decreased from $60M to $51M — a 15.0% year-over-year decrease (period ending December 2025). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

OSE Immunotherapeutics S.A. reported $51M in total liabilities as of December 2025. That compares with $60M in the prior-year period — down 15.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total liabilities of $51M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for OSE Immunotherapeutics S.A., and consider following ORPOF for alerts when major investors trade the stock.

OSE Immunotherapeutics S.A. is classified in the Healthcare sector. On total liabilities, it currently shows $51M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing ORPOF with unrelated industries.